News
A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun to lift use of the weight loss drug, but the company will ...
The U.S. FDA ban on compounded versions of Novo Nordisk's Wegovy has increased its prescriptions by 33%. Despite this, ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Since the US Food and Drug Administration (FDA) implemented a ban on ‘compounded’ versions of Wegovy on 22 May, new ...
Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...
CVS acknowledged that Zepbound has been shown to help people lose more weight than Wegovy, but that Wegovy can still help ...
US lawmakers are pushing the Food and Drug Administration to control the increasing market of fake weight-loss medications.
As many as 19 of the top 20 publicly-traded global biopharma companies reported revenue growth in 2024, with an overall 7.9% ...
The program was formally launched July 28 at a signing ceremony at Wake Tech’s Beltline Education Center in Raleigh. Leaders ...
13h
Medpage Today on MSNCognitive Scores Improve With Lifestyle Changes, Trial Shows"While U.S. POINTER was designed and powered as a head-to-head comparison of the two interventions, and a statistically ...
Three Motley Fool contributors have picked surprisingly underrated stocks to buy right now. Here's why they chose big pharma ...
DehydraTECH-semaglutide reduces overall side effects by 36.5% as compared to Rybelsus®DehydraTECH-semaglutide reduces gastrointestinal side effects by 43.5% as compared to Rybelsus®DehydraTECH-GLP-1 s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results